Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Festuccia Claudio
Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer Development and Progression: Insight to Therapy
Clinical Cancer Drugs
Cancer Research
Toxicology
Oncology
Pharmaceutics
Pharmacology
Related publications
Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway
Current Cancer Drug Targets
Cancer Research
Drug Discovery
Oncology
Pharmacology
Targeting the PI3K/AKT Pathway for the Treatment of Prostate Cancer
Clinical Cancer Research
Cancer Research
Oncology
Targeting the PI3K/Akt/mTOR Signalling Pathway in Cystic Fibrosis
Scientific Reports
Multidisciplinary
Targeting the PI3K/AKT/MTOR Pathway in KSHV-associated Cancers
Infectious Agents and Cancer
Cancer Research
Epidemiology
Oncology
Infectious Diseases
Pre-Clinical Activity of Targeting the PI3K/Akt/mTOR Pathway in Burkitt Lymphoma
Oncotarget
Oncology
Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
PI3K/AKT/mTOR Pathway Alterations Promote Malignant Progression and Xenograft Formation in Oligodendroglial Tumors
Clinical Cancer Research
Cancer Research
Oncology
PSMA Redirects MAPK to PI3K-AKT Signaling to Promote Prostate Cancer Progression
Molecular and Cellular Oncology
Cancer Research
Molecular Medicine
Isorhamnetin Inhibited the Proliferation and Metastasis of Androgen-Independent Prostate Cancer Cells by Targeting the Mitochondrion-Dependent Intrinsic Apoptotic and PI3K/Akt/mTOR Pathway
Bioscience Reports
Biochemistry
Cell Biology
Molecular Biology
Biophysics
